Influence of aromatase inhibitors on insulin sensitivity, liver and heart function in obese men.
Phase of Trial: Phase IV
Latest Information Update: 07 Jun 2017
Price : $35 *
At a glance
- Drugs Letrozole (Primary)
- Indications Obesity
- Focus Pharmacodynamics
- Acronyms HEPAROB
- 15 Aug 2015 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
- 02 Jun 2015 Planned End Date changed from 1 Mar 2015 to 1 Sep 2015 as reported by ClinicalTrials.gov
- 02 Jun 2015 Planned primary completion date changed from 1 Mar 2015 to 1 Sep 2015 as reported by ClinicalTrials.gov